AVTX holders · CITADEL ADVISORS LLC 13F · AVTX stock
CITADEL ADVISORS LLC Avalo Therapeutics Inc (AVTX) 13F holding
CITADEL ADVISORS LLC reported 193,735 AVTX shares valued at $2.9M as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.
This is the newest AVTX 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the AVTX holders table.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 193,735 | $2.9M | COM NEW |
| 2025-12-31 | 419,491 | $7.6M | COM NEW |
| 2025-09-30 | 481,669 | $6.1M | COM NEW |
Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.